Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not?

Epithelial-Mesenchymal Transitions in Development and Disease

Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931 · see citing works

Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy

Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · see citing works

Macrophage Diversity Enhances Tumor Progression and Metastasis

Qian, B., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,178 · see citing works

Microenvironmental regulation of metastasis

Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684 · see citing works

Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.

Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251 · see citing works

Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

Miller, K. D., Wang, M., Gralow, J. R., Dickler, M. N., Cobleigh, M., Perez, E. A., Shenkier, T. N., Cella, D. F., & Davidson, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072113 · Cited by 3,077 · see citing works

Modes of resistance to anti-angiogenic therapy

Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953 · see citing works

Collective cell migration in morphogenesis, regeneration and cancer

Friedl, P., & Gilmour, D. T. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2720 · Cited by 2,668 · see citing works

Metastasis: from dissemination to organ-specific colonization

Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2622 · Cited by 2,637 · see citing works

Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502 · see citing works

Hypoxia-inducible factors and the response to hypoxic stress

Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380 · see citing works

Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis

Pàez‐Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Viñals, F., Inoue, M., Bergers, G., Hanahan, D., & Casanovas, O. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.027 · Cited by 2,344 · see citing works

A Perivascular Niche for Brain Tumor Stem Cells

Calabrese, C. R., Poppleton, H., Koçak, M., Hogg, T. L., Fuller, C. E., Hamner, J. B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,203 · see citing works

Heart-Lung Transplantation

Yarbrough, W. M., Robbins, R. C., & Mallidi, H. R. (2016) · CRC Press eBooks · doi:10.3109/9781439802571-25 · Cited by 2,161 · see citing works

Hypoxia and inflammation

Eltzschig, H. K., & Carmeliet, P. (2011) · New England Journal of Medicine · doi:10.1056/nejmra0910283 · Cited by 2,061 · see citing works

AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

Batchelor, T. T., Sorensen, A. G., di Tomaso, E., Zhang, W.-T., Duda, D. G., Cohen, K. S., Kozak, K. R., Cahill, D. P., Chen, P.-J., Zhu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.021 · Cited by 1,769 · see citing works

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712 · see citing works

Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis

Ebos, J. M. L., Lee, C. R., Cruz‐Muñoz, W., Bjarnason, G. A., Christensen, J. G., & Kerbel, R. S. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.021 · Cited by 1,710 · see citing works

Molecular Distinction and Angiogenic Interaction between Embryonic Arteries and Veins Revealed by ephrin-B2 and Its Receptor Eph-B4

Wang, H. U., Chen, Z., & Anderson, D. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81436-1 · Cited by 1,678 · see citing works

Models, mechanisms and clinical evidence for cancer dormancy

Aguirre‐Ghiso, J. A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2256 · Cited by 1,673 · see citing works

Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells

Gaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J. F., Harrington, K., & Sahai, E. (2007) · Nature Cell Biology · doi:10.1038/ncb1658 · Cited by 1,589 · cited 1× · see citing works

Oxygen in Stem Cell Biology: A Critical Component of the Stem Cell Niche

Mohyeldin, A., Garzón-Muvdi, T., & Quiñones‐Hinojosa, A. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.07.007 · Cited by 1,536 · see citing works

Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system

Augustin, H. G., Koh, G. Y., Thurston, G., & Alitalo, K. K. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2639 · Cited by 1,460 · see citing works

HIF-1: upstream and downstream of cancer metabolism

Semenza, G. L. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.10.009 · Cited by 1,381 · see citing works

Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells

Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.018 · Cited by 1,354 · see citing works

Tumor Self-Seeding by Circulating Cancer Cells

Kim, M.-Y., Oskarsson, T., Acharyya, S., Nguyen, D. X., Zhang, X. H.-F., Norton, L., & Massagué, J. (2009) · Cell · doi:10.1016/j.cell.2009.11.025 · Cited by 1,335 · see citing works

Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche

Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., Le, Q.-T., & Giaccia, A. J. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.11.012 · Cited by 1,231 · see citing works

Glioblastoma stem-like cells give rise to tumour endothelium

Wang, R., Chadalavada, K., Wilshire, J. A., Kowalik, U., Hovinga, K. E., Geber, A. B., Fligelman, B., Leversha, M. A., Brennan, C., & Tabar, V. S. (2010) · Nature · doi:10.1038/nature09624 · Cited by 1,203 · see citing works

Real-time imaging reveals the single steps of brain metastasis formation.

Kienast, Y., von Baumgarten, L., Fuhrmann, M., Klinkert, W. E. F., Goldbrunner, R., Herms, J., & Winkler, F. (2010) · Nature Medicine · doi:10.1038/nm.2072 · Cited by 1,138 · see citing works

HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion

Du, R., Lu, K. V., Petritsch, C. K., Liu, P., Ganß, R., Passegue, E. A., Song, H., VandenBerg, S. R., Johnson, R. S., Werb, Z., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.034 · Cited by 1,131 · see citing works

Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment

Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P., & Brugge, J. S. (2009) · Nature · doi:10.1038/nature08268 · Cited by 1,031 · see citing works

TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4

Padua, D. M., Zhang, X. H.-F., Wang, Q., Nadal, C., Gerald, W. L., Gomis, R. R., & Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.01.046 · Cited by 947 · see citing works

Endothelial-Mural Cell Signaling in Vascular Development and Angiogenesis

Gaengel, K., Genové, G., Armulik, A., & Betsholtz, C. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.161521 · Cited by 933 · see citing works

Rapid vascular regrowth in tumors after reversal of VEGF inhibition

Mancuso, M. R., Davis, R. B., Norberg, S. M., O’Brien, S., Sennino, B., Nakahara, T., Yao, V., Inai, T., Brooks, P. C., Freimark, B. D., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24612 · Cited by 814 · see citing works

Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization

Mazzone, M., Dettori, D., de Oliveira, R. L., Loges, S., Schmidt, T., Jonckx, B., Tian, Y.-M., Lanahan, A. A., Pollard, P. J., de Almodóvar, C. R., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.020 · Cited by 803 · see citing works

Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival

Escudier, B. J., Joaquim Bellmunt, B., Négrier, S., Bajetta, E., Melichar, B., Sergio Bracarda, A., Ravaud, A., Golding, S., Jethwa, S., & Šneller, V. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7849 · Cited by 802 · see citing works

The Control of Vascular Integrity by Endothelial Cell Junctions: Molecular Basis and Pathological Implications

Dejana, E., Tournier‐Lasserve, E., & Weinstein, B. M. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.004 · Cited by 787 · see citing works

Hypoxia and hypoxia-inducible factors: master regulators of metastasis

Lu, X., & Kang, Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1360 · Cited by 723 · see citing works

HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PlGF

Rolny, C., Mazzone, M., Tugues, S., Laoui, D., Johansson, I., Coulon, C., Squadrito, M. L., Segura, I., Li, X., Knevels, E., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.11.009 · Cited by 695 · cited 1× · see citing works

Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis.

Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A., & Ferrara, N. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117857 · Cited by 694 · see citing works

Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)

Reck, M., von Pawel, J., Zatloukal, P., Ramlau, R., Gorbounova, V., Hirsh, V., Leighl, N., Mezger, J., Archer, V., Moore, N., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq020 · Cited by 638 · see citing works

Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung Metastasis

Gao, D., Nolan, D. J., Mellick, A. S., Bambino, K., McDonnell, K., & Mittal, V. (2008) · Science · doi:10.1126/science.1150224 · Cited by 632 · see citing works

Malignant cells facilitate lung metastasis by bringing their own soil

Duda, D. G., Duyverman, A. M. M. J., Kohno, M., Snuderl, M., Steller, E. J. A., Fukumura, D., & Jain, R. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016234107 · Cited by 594 · see citing works

Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08

Allegra, C. J., Yothers, G., O’Connell, M. J., Sharif, S., Petrelli, N. J., Colangelo, L. H., Atkins, J. N., Seay, T. E., Fehrenbacher, L., Goldberg, R. M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.0855 · Cited by 590 · see citing works

Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors

Butler, J. M., Kobayashi, H., & Rafii, S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2791 · Cited by 578 · see citing works

FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?

Fischer, C., Mazzone, M., Jonckx, B., & Carmeliet, P. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2524 · Cited by 566 · see citing works

Multi-Kinase Inhibitor E7080 Suppresses Lymph Node and Lung Metastases of Human Mammary Breast Tumor MDA-MB-231 via Inhibition of Vascular Endothelial Growth Factor-Receptor (VEGF-R) 2 and VEGF-R3 Kinase

Matsui, J., Funahashi, Y., Uenaka, T., Watanabe, T., Tsuruoka, A., & Asada, M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5270 · Cited by 532 · see citing works

Transdifferentiation of glioblastoma cells into vascular endothelial cells

Soda, Y., Marumoto, T., Friedmann‐Morvinski, D., Soda, M., Liu, F., Michiue, H., Pastorino, S., Yang, M., Hoffman, R. M., Kesari, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016030108 · Cited by 516 · see citing works

Mechanisms of Motility in Metastasizing Cells

Yilmaz, M., & Christofori, G. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0139 · Cited by 474 · see citing works

VEGF-A and the Induction of Pathological Angiogenesis

Nagy, J. A., Dvořàk, A. M., & Dvorak, H. F. (2007) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.134925 · Cited by 472 · see citing works

Hypoxia-inducible factor 2α regulates macrophage function in mouse models of acute and tumor inflammation

Imtiyaz, H. Z., Williams, E. P., Hickey, M. M., Patel, S. A., Durham, A. C., Yuan, L.-J., Hammond, R., Gimotty, P. A., Keith, B., & Simon, M. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39506 · Cited by 461 · see citing works

Hypoxia inducible factors in cancer stem cells

Heddleston, J. M., Li, Z., Lathia, J. D., Bao, S., Hjelmeland, A. B., & Rich, J. N. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605551 · Cited by 453 · see citing works

Heterogeneity of the Tumor Vasculature

Nagy, J. A., Chang, S.-H., Shih, S., Dvořàk, A. M., & Dvorak, H. F. (2010) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1253454 · Cited by 422 · see citing works

Regulation of Angiogenesis by Oxygen and Metabolism

Fraisl, P., Mazzone, M., Schmidt, T., & Carmeliet, P. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.003 · Cited by 409 · see citing works

The hypoxic response of tumors is dependent on their microenvironment

Blouw, B., Song, H., Tihan, T., Bosze, J., Ferrara, N., Gerber, H.-P., Johnson, R. S., & Bergers, G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00194-6 · Cited by 408 · see citing works

Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion

Zagzag, D., Lukyanov, Y., Lan, L., Ali, M., Esencay, M., Méndez, O., Yee, H. T., Voura, E. B., & Newcomb, E. W. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700482 · Cited by 396 · see citing works

Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity

Moeller, B. J., Dreher, M. R., Rabbani, Z. N., Schroeder, T., Cao, Y., Li, C. Y., & Dewhirst, M. W. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.016 · Cited by 374 · see citing works

Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects

Zhang, W., Zhu, X., Sun, H., Xiong, Y., Zhuang, P., Xu, H., Kong, L., Wang, L., Wu, W., & Tang, Z. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2904 · Cited by 373 · see citing works

Angiopoietin-Like 4 Is a Proangiogenic Factor Produced during Ischemia and in Conventional Renal Cell Carcinoma

Jan, S. L., Amy, C., Cazes, A., Monnot, C., Lamandé, N., Favier, J., Philippe, J., Sibony, M., Gasc, J., Corvol, P. L., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64285-x · Cited by 342 · see citing works

Tube Travel: The Role of Proteases in Individual and Collective Cancer Cell Invasion

Friedl, P., & Wolf, K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0784 · Cited by 338 · see citing works

Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis.

Shaheen, R. M., Davis, D. W., Liu, W., Zebrowski, B. K., Wilson, M. R., Bucana, C. D., McConkey, D. J., McMahon, G., & Ellis, L. M. (1999) · PubMed · Cited by 334 · see citing works

Edema Control by Cediranib, a Vascular Endothelial Growth Factor Receptor–Targeted Kinase Inhibitor, Prolongs Survival Despite Persistent Brain Tumor Growth in Mice

Kamoun, W. S., Ley, C. D., Farrar, C. T., Duyverman, A. M., Lahdenranta, J., Lacorre, D. A., Batchelor, T. T., di Tomaso, E., Duda, D. G., Munn, L. L., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9356 · Cited by 309 · see citing works

Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer

Franovic, A., Gunaratnam, L., Smith, K., Robert, I., Patten, D. A., & Lee, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702387104 · Cited by 282 · see citing works

Tie2-Expressing Monocytes and Tumor Angiogenesis: Regulation by Hypoxia and Angiopoietin-2

Lewis, C. E., Palma, M. D., & Naldini, L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1684 · Cited by 261 · see citing works

Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121.

Asano, M., Yukita, A., Matsumoto, T., et al. (1995) · PubMed · Cited by 260 · see citing works

Endothelial deletion of hypoxia-inducible factor–2α (HIF-2α) alters vascular function and tumor angiogenesis

Skuli, N., Liu, L., Runge, A., Wang, T., Yuan, L., Patel, S., Iruela‐Arispe, M. L., Simon, M. C., & Keith, B. (2009) · Blood · doi:10.1182/blood-2008-12-193581 · Cited by 256 · see citing works

Pulmonary Vascular Destabilization in the Premetastatic Phase Facilitates Lung Metastasis

Huang, Y., Song, N., Ding, Y., Yuan, S., Li, X., Cai, H., Shi, H., & Luo, Y. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4382 · Cited by 247 · see citing works

Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates

Koike, T., Kimura, N., Miyazaki, K., Yabuta, T., Kumamoto, K., Takenoshita, S., Chen, J., Kobayashi, M., Hosokawa, M., Taniguchi, A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402088101 · Cited by 246 · see citing works

Antiangiogenic therapies for high-grade glioma

Norden, A. D., Drappatz, J., & Wen, P. Y. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.159 · Cited by 246 · see citing works

Hypoxia Upregulates the Synthesis of TGF-β1 by Human Dermal Fibroblasts

Falanga, V., Qian, V. S. W., Danielpour, D., Katz, M. H., Roberts, A. B., & Sporn, M. B. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12483126 · Cited by 231 · see citing works

Regression of established tumors and metastases by potent vascular endothelial growth factor blockade

Huang, J., Frischer, J. S., Serur, A., Kadenhe, A., Yokoi, A., McCrudden, K. W., New, T. N., O’Toole, K., Zabski, S. M., Rudge, J. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432908100 · Cited by 228 · see citing works

HIF1-alpha functions as a tumor promoter in cancer-associated fibroblasts, and as a tumor suppressor in breast cancer cells

Chiavarina, B., Whitaker‐Menezes, D., Migneco, G., Martinez‐Outschoorn, U., Pavlides, S., Howell, A., Tanowitz, H. B., Casimiro, M. C., Wang, C., Pestell, R. G., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.17.12908 · Cited by 222 · see citing works

The role of the organ microenvironment in brain metastasis

Fidler, I. J. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.12.009 · Cited by 217 · see citing works

Lysyl Oxidase Mediates Hypoxic Control of Metastasis

Erler, J. T., & Giaccia, A. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3197 · Cited by 214 · see citing works

Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma

Wu, X., Xie, G. R., & Chen, D. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04997.x · Cited by 213 · see citing works

Hypoxia: A Link between Fibrogenesis, Angiogenesis, and Carcinogenesis in Liver Disease

Rosmorduc, O., & Housset, C. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255355 · Cited by 208 · see citing works

Metastasis‐associated protein 1 enhances stability of hypoxia‐inducible factor‐1α protein by recruiting histone deacetylase 1

Yoo, Y., Kong, G., & Lee, M. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601025 · Cited by 200 · see citing works

Glioblastoma Recurrence after Cediranib Therapy in Patients: Lack of “Rebound” Revascularization as Mode of Escape

di Tomaso, E., Snuderl, M., Kamoun, W. S., Duda, D. G., Auluck, P. K., Fazlollahi, L., Andronesi, O. C., Frosch, M. P., Wen, P. Y., Plotkin, S. R., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2602 · Cited by 200 · see citing works

Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation

Hiratsuka, S., Goel, S., Kamoun, W. S., Maru, Y., Fukumura, D., Duda, D. G., & Jain, R. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100446108 · Cited by 196 · see citing works

Signalling pathways in vasculogenic mimicry.

Paulis, Y. W. J., Soetekouw, P., Verheul, H. M. W., Tjan-Heijnen, V., & Griffioen, A. (2010) · Biochimica et Biophysica Acta · doi:10.1016/j.bbcan.2010.01.001 · Cited by 194 · see citing works

Cancer Dissemination—Lessons from Leukocytes

Madsen, C. D., & Sahai, E. A. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.06.013 · Cited by 194 · see citing works

Proangiogenic Role of Tumor–Activated Hepatic Stellate Cells in Experimental Melanoma Metastasis

Olaso, E., Salado, C., Egilegor, E., Gutierrez, V., Santisteban, A., Sancho‐Bru, P., Friedman, S. L., & Vidal‐Vanaclocha, F. (2003) · Hepatology · doi:10.1053/jhep.2003.50068 · Cited by 190 · see citing works

VEGF inhibition: insights from preclinical and clinical studies

Crawford, Y., & Ferrara, N. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0675-8 · Cited by 187 · see citing works

Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways

Pignochino, Y., Grignani, G., Cavalloni, G., Motta, M., Tapparo, M., Bruno, S., Bottos, A., Gammaitoni, L., Migliardi, G., Camussi, G., et al. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-118 · Cited by 180 · see citing works

The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation

Bedogni, B., Welford, S. M., Cassarino, D. S., Nickoloff, B. J., Giaccia, A. J., & Powell, M. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.11.005 · Cited by 178 · see citing works

NEUTRALIZING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIBODY INHIBITS FURTHER GROWTH OF ESTABLISHED PROSTATE CANCER AND METASTASES IN A PRE-CLINICAL MODEL

Melnyk, O. O., ZIMMERMAN, M., KIM, K. J., & Shuman, M. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)61829-9 · Cited by 162 · see citing works

Pericytes: gatekeepers in tumour cell metastasis?

Gerhardt, H., & Semb, H. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0258-2 · Cited by 162 · see citing works

Direct Evidence that Bevacizumab, an Anti-VEGF Antibody, Up-regulates SDF1α, CXCR4, CXCL6, and Neuropilin 1 in Tumors from Patients with Rectal Cancer

Xu, L., Duda, D. G., di Tomaso, E., Ancukiewicz, M., Chung, D. C., Lauwers, G. Y., Samuel, R., Shellito, P. C., Czito, B. G., Lin, P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2099 · Cited by 161 · see citing works

Disease Course Patterns After Discontinuation of Bevacizumab: Pooled Analysis of Randomized Phase III Trials

Miles, D., Harbeck, N., Escudier, B. J., Hurwitz, H. I., Saltz, L. B., Cutsem, E. V., Cassidy, J., Mueller, B., & Sirzén, F. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.2794 · Cited by 158 · see citing works

The receptor tyrosine kinase inhibitor SU11248 impedes endothelial cell migration, tubule formation, and blood vessel formation in vivo, but has little effect on existing tumor vessels

Osusky, K. L., Hallahan, D. E., Fu, A., Ye, F., Shyr, Y., & Geng, L. (2004) · Angiogenesis · doi:10.1007/s10456-004-3149-y · Cited by 154 · see citing works

PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth

Bais, C., Wu, X., Yao, J. J., Yang, S., Crawford, Y., McCutcheon, K. M., Tan, C., Kolumam, G. A., Vernes, J.-M., Eastham‐Anderson, J., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.033 · Cited by 154 · see citing works

Double Antiangiogenic Protein, DAAP, Targeting VEGF-A and Angiopoietins in Tumor Angiogenesis, Metastasis, and Vascular Leakage

Koh, Y. J., Kim, H.-Z., Hwang, S.-I., Lee, J. E., Oh, N., Jung, K., Kim, M., Kim, K. E., Kim, H., Lim, N. K., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.07.001 · Cited by 153 · see citing works

Effects of Anti-VEGF Treatment Duration on Tumor Growth, Tumor Regrowth, and Treatment Efficacy

Bagri, A., Berry, L., Gunter, B., Singh, M., Kasman, I. M., Damico, L. A., Xiang, H., Schmidt, M., Fuh, G., Hollister, B. A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3100 · Cited by 140 · see citing works

Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1+ Leukemia

Schmidt, T., Masouleh, B. K., Loges, S., Cauwenberghs, S., Fraisl, P., Maes, C., Jonckx, B., Keersmaecker, K. D., Kleppe, M., Tjwa, M., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.007 · Cited by 135 · see citing works

Hypoxia-inducible factor-1α and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients

Kallergi, G., Markomanolaki, H., Giannoukaraki, V., Papadaki, M. A., Strati, A. D., Lianidou, E. S., Georgoulias, V., Mavroudis, D., & Agelaki, S. (2009) · Breast Cancer Research · doi:10.1186/bcr2452 · Cited by 134 · see citing works

Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth.

Melnyk, O. O., Shuman, M. A., & Kim, K. J. (1996) · PubMed · Cited by 133 · see citing works

Vascular Endothelial Growth Factor Trap Combined with Paclitaxel Strikingly Inhibits Tumor and Ascites, Prolonging Survival in a Human Ovarian Cancer Model

Hu, L., Hofmann, J., Holash, J. A., Yancopoulos, G. D., Sood, A. K., & Jaffe, R. B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0910 · Cited by 127 · see citing works

CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti‐VEGF treatment or docetaxel in a transgenic mouse model

Hassan, S. N., Buchanan, M., Jahan, K., Aguilar‐Mahecha, A., Gaboury, L. A., Muller, W. J., Al-Sawafi, Y., Mourskaia, A., Siegel, P. M., Salvucci, O., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25665 · Cited by 126 · see citing works

Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.

Sweeney, P., Karashima, T., Kim, S. J., Kedar, D. J., Mian, B. M., HUANG, S. F., Baker, C. H., Fan, Z., Hicklin, D. J., Pettaway, C. A., et al. (2002) · PubMed · Cited by 120 · see citing works

Hypoxia inducible factor-2α: a critical mediator of aggressive tumor phenotypes

Qing, G., & Simon, M. C. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.12.001 · Cited by 117 · see citing works

Glioblastoma, Cancer Stem Cells and Hypoxia

Bar, E. E. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00460.x · Cited by 117 · see citing works

VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop

González-Moreno, Ó., Lecanda, J., Green, J. E., Segura, V., Catena, R., Serrano, D., & Calvo, A. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.11.020 · Cited by 114 · see citing works

The role of metastasis suppressor genes in metastatic dormancy

Horak, C. E., LEE, J. H., Marshall, J.-C. A., et al. (2008) · Apmis · doi:10.1111/j.1600-0463.2008.01027.x · Cited by 111 · see citing works

Vascular Endothelial Growth Factor Trap Blocks Tumor Growth, Metastasis Formation, and Vascular Leakage in an Orthotopic Murine Renal Cell Cancer Model

Verheul, H. M. W., Hammers, H. J., van Erp, K., Wei, Y., Sanni, T. B., Salumbides, B. C., Qian, D. Z., Yancopoulos, G. D., & Пили, Р. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2553 · Cited by 111 · see citing works

Chapter 3 Tumor Dormancy and Metastasis

Hedley, B. D., & Chambers, A. F. (2009) · Advances in cancer research · doi:10.1016/s0065-230x(09)02003-x · Cited by 110 · see citing works

Oxygen regulates epithelial-to-mesenchymal transition: insights into molecular mechanisms and relevance to disease

Haase, V. H. (2009) · Kidney International · doi:10.1038/ki.2009.222 · Cited by 110 · see citing works

Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms' tumor

Rowe, D. H., Huang, J., Kayton, M. L., Thompson, R., Troxel, A. B., O’Toole, K., Yamashiro, D. J., Stolar, C. J. H., & Kandel, J. J. (2000) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(00)80008-1 · Cited by 109 · see citing works

Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib

Padera, T. P., Kuo, A. H., Hoshida, T., Liao, S., Shah, J. L., Kozak, K. R., Fukumura, D., & Jain, R. K. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0182 · Cited by 109 · see citing works

Hypoxia-Inducible Factor 1α Mediates Anoikis Resistance via Suppression of α5 Integrin

Rohwer, N., Welzel, M., Daskalow, K., Pfander, D., Wiedenmann, B. J., Detjen, K. M., & Cramer, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1839 · Cited by 109 · see citing works

Hypoxia Helps Glioma to Fight Therapy

Murphy, V. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909788166637 · Cited by 108 · see citing works

The role of HIF prolyl hydroxylases in tumour growth

Jokilehto, T., & Jaakkola, P. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01030.x · Cited by 102 · see citing works

Bevacizumab Suppression of Establishment of Micrometastases in Experimental Ocular Melanoma

Yang, H., Jager, M. J., & Grossniklaus, H. E. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4755 · Cited by 96 · see citing works

Anti‐VEGF‐A therapy reduces lymphatic vessel density and expression of VEGFR‐3 in an orthotopic breast tumor model

Whitehurst, B. D., Flister, M. J., Bagaitkar, J., Volk, L. D., Bivens, C., Pickett, B., Castro‐Rivera, E., Brekken, R. A., Gerard, R. D., & Ran, S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22937 · Cited by 95 · see citing works

C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells

Hiratsuka, S., Duda, D. G., Huang, Y., Goel, S., Sugiyama, T., Nagasawa, T., Fukumura, D., & Jain, R. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016917108 · Cited by 91 · see citing works

Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials

Valachis, A., Polyzos, N. P., Patsopoulos, N. A., Georgoulias, V., Mavroudis, D., & Mauri, D. N. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0727-0 · Cited by 91 · see citing works

Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression

Maegdefrau, U., Amann, T., Winklmeier, A., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2563 · Cited by 91 · see citing works

Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis

Kim, M. P., Park, S. I., Kopetz, S., & Gallick, G. E. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0682-9 · Cited by 89 · see citing works

Anti-tumor effect of CT-322 as an Adnectin inhibitor of vascular endothelial growth factor receptor-2

Mamluk, R., Carvajal, I. M., Morse, B. A., et al. (2010) · mAbs · doi:10.4161/mabs.2.2.11304 · Cited by 79 · see citing works

In Vivo Antitumor and Antimetastatic Activity of Sunitinib in Preclinical Neuroblastoma Mouse Model

Zhang, L., Smith, K. M., Chong, A. L., Stempak, D., Yeger, H., Marrano, P. M., Thorner, P. S., Irwin, M. S., Kaplan, D. R., & Baruchel, S. (2009) · Neoplasia · doi:10.1593/neo.09166 · Cited by 76 · see citing works

Targeting Angiogenesis Driven by Vascular Endothelial Growth Factors Using Antibody-Based Therapies

Grothey, A., & Ellis, L. M. (2008) · The Cancer Journal · doi:10.1097/ppo.0b013e318178d9de · Cited by 76 · see citing works

Hyperoxic Treatment Induces Mesenchymal-to-Epithelial Transition in a Rat Adenocarcinoma Model

Moen, I. N., Oyan, A. M., Kalland, K.-H., Tronstad, K. J., Akslen, L. A., Chekenya, M., Sakariassen, P. Ø., Reed, R. K., & Stuhr, L. E. B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006381 · Cited by 76 · see citing works

The HIF-2α-Driven Pseudo-Hypoxic Phenotype in Tumor Aggressiveness, Differentiation, and Vascularization

Pietras, A., Johnsson, A. S., & Påhlman, S. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_72 · Cited by 58 · see citing works

Suppression of Tumor Growth and Metastasis by Simultaneously Blocking Vascular Endothelial Growth Factor (VEGF)–A and VEGF-C with a Receptor-Immunoglobulin Fusion Protein

Zhang, D., Li, B., Shi, J., Zhao, L., Zhang, X., Wang, C., Hou, S., Qian, W., Kou, G., Wang, H., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3488 · Cited by 57 · see citing works

PTEN suppression of YY1 induces HIF-2 activity in von hippel lindau null renal cell carcinoma

Petrella, B. L., & Brinckerhoff, C. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.14.8880 · Cited by 55 · see citing works

The Angiogenic Switch: Implications in the Regulation of Tumor Dormancy

Moserle, L., Amadori, A., & Indraccolo, S. (2009) · Current Molecular Medicine · doi:10.2174/156652409789712800 · Cited by 54 · see citing works

Anti–Placental Growth Factor Reduces Bone Metastasis by Blocking Tumor Cell Engraftment and Osteoclast Differentiation

Coenegrachts, L., Maes, C., Torrekens, S., Looveren, R. V., Mazzone, M., Guise, T. A., Bouillon, R., Stassen, J.-M., Carmeliet, P., & Carmeliet, G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4092 · Cited by 51 · see citing works

Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes

Lang, S. A., Schachtschneider, P., Moser, C., Mori, A., Hackl, C., Gaumann, A. K. A., Batt, D. B., Schlitt, H. J., Geissler, E. K., & Stoeltzing, O. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0373 · Cited by 51 · see citing works

The Tumor Microenvironment and DNA Repair

Klein, T. J., & Glazer, P. M. (2010) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.05.006 · Cited by 50 · see citing works

Cediranib/AZD2171 Inhibits Bone and Brain Metastasis in a Preclinical Model of Advanced Prostate Cancer

Yin, J. J., Zhang, L., Munasinghe, J., Linnoila, R. I., & Kelly, K. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1435 · Cited by 48 · see citing works

Hypoxia Increases Placenta Growth Factor Expression in Human Myocardium and Cultured Neonatal Rat Cardiomyocytes

Torry, R. J., Tomanek, R. J., Zheng, W., et al. (2009) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2008.11.917 · Cited by 44 · see citing works

Differential effects of the vascular endothelial growth factor receptor inhibitor PTK787/ZK222584 on tumor angiogenesis and tumor lymphangiogenesis

Schomber, T., Zumsteg, A., Strittmatter, K., Crnić, I., Antoniadis, H., Littlewood-Evans, A. J., Wood, J. M., & Christofori, G. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0679 · Cited by 43 · see citing works

Suppression of primary tumor growth in a mouse model of human neuroblastoma

Rowe, D. H., Huang, J., Li, J., et al. (2000) · Journal of Pediatric Surgery · doi:10.1053/jpsu.2000.6946 · Cited by 41 · see citing works

Metastasis in Melanoma Xenografts Is Associated with Tumor Microvascular Density Rather than Extent of Hypoxia

Rofstad, E. K., & Mathiesen, B. S. (2010) · Neoplasia · doi:10.1593/neo.10712 · Cited by 39 · see citing works

Sunitinib Prolongs Survival in Genetically Engineered Mouse Models of Multistep Lung Carcinogenesis

Gandhi, L., McNamara, K. L., Li, D., Borgman, C. L., McDermott, U., Brandstetter, K. A., Padera, R. F., Chirieac, L. R., Settleman, J. E., & Wong, K. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0213 · Cited by 39 · see citing works

Kinases as Upstream Regulators of the HIF System: Their Emerging Potential as Anti-Cancer Drug Targets

Dimova, E. Y., Michiels, C., & Kietzmann, T. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789649358 · Cited by 37 · see citing works

Hypoxia induces PTHrP gene transcription in human cancer cells through the HIF-2α

Manisterski, M., Golan, M., Amir, S., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.18.12931 · Cited by 35 · see citing works

Effect of Bevacizumab, a Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor, on Peritoneal Metastasis of MNK-45P Human Gastric Cancer in Mice

Ninomiya, S., Inomata, M., Tajima, M., et al. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.08.017 · Cited by 34 · see citing works

Hypoxia and Metastasis in Breast Cancer

Rundqvist, H., & Johnson, R. S. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_77 · Cited by 31 · see citing works

Biallelic mutations of the Tsc2 gene in chemically induced rat renal cell carcinoma

Satake, N., Urakami, S., Hirayama, Y., Izumi, K., & Hino, O. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980911)77:6 · Cited by 30 · see citing works

New evidence for tumour embolism as a mode of metastasis

Hart, I. R. (2009) · The Journal of Pathology · doi:10.1002/path.2616 · Cited by 28 · see citing works

Oxygen Sensing: A Common Crossroad in Cancer and Neurodegeneration

Quaegebeur, A., & Carmeliet, P. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_83 · Cited by 27 · see citing works

Evaluation of Vascular Endothelial Growth Factor Blockade and Matrix Metalloproteinase Inhibition as a Combination Therapy for Experimental Human Pancreatic Cancer

Hotz, H. G., Hines, O. J., Hotz, B., et al. (2003) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(02)00157-9 · Cited by 26 · see citing works

Tumor-induced endothelial cell apoptosis: Roles of NAD(P)H oxidase-derived reactive oxygen species

Lin, R., Wang, T.-P., Hung, R., Chuang, Y., Chien, C.-C. M., & Chang, H. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22504 · Cited by 24 · see citing works

Efficacy of the combined use of bevacizumab and irinotecan as a postoperative adjuvant chemotherapy in colon carcinoma

Mizobe (1994) · Oncology Reports · doi:10.3892/or_00000036 · Cited by 17 · see citing works

Suppressive effect of bevacizumab on peritoneal dissemination from gastric cancer in a peritoneal metastasis model

Imaizumi, T., Aoyagi, K., Miyagi, M., et al. (2010) · Surgery Today · doi:10.1007/s00595-009-4154-y · Cited by 15 · see citing works

Retention of prolyl hydroxylase PHD2 in the cytoplasm prevents PHD2-induced anchorage-independent carcinoma cell growth

Jokilehto, T., Högel, H., Heikkinen, P. T., Rantanen, K., Elenius, K., Sundström, J. T. T., & Jaakkola, P. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.012 · Cited by 13 · see citing works

Hungry for Blood Vessels: Linking Metabolism and Angiogenesis

Fraisl, P., Baes, M. I., & Carmeliet, P. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.02.009 · Cited by 13 · see citing works

Combination Therapy of Interleukin-2 and Sorafenib Improves Survival Benefits and Prevents Spontaneous Pulmonary Metastasis in Murine Renal Cell Carcinoma Models

Amagai, Y., Matsumoto, M., Hojo, K., et al. (2010) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp200 · Cited by 6 · see citing works

Hypoxic control of metastasis

Rankin, E. B., & Giaccia, A. J. (2016) · Science · doi:10.1126/science.aaf4405 · Cited by 1,340 · see citing works

Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development

Kucharzewska, P., Christianson, H. C., Welch, J. E., Svensson, K. J., Fredlund, E., Ringnér, M., Mörgelin, M., Bourseau-Guilmain, E., Bengzon, J., & Belting, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220998110 · Cited by 939 · see citing works

Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy

Cantelmo, A. R., Conradi, L.-C., Brajic, A., Goveia, J., Kalucka, J., Pircher, A., Chaturvedi, P., Hol, J., Thienpont, B., Teuwen, L.-A., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.006 · Cited by 659 · see citing works

Bimodal Tumor-Targeting from Microenvironment Responsive Hyaluronan Layer-by-Layer (LbL) Nanoparticles

Dreaden, E. C., Morton, S. W., Shopsowitz, K. E., Choi, J.-H., Deng, Z. J., Cho, N.-J., & Hammond, P. T. (2014) · ACS Nano · doi:10.1021/nn502861t · Cited by 179 · see citing works

Wiring the Vascular Network with Neural Cues: A CNS Perspective

Wälchli, T., Wacker, A., Frei, K., Regli, L., Schwab, M. E., Hoerstrup, S. P., Gerhardt, H., & Engelhardt, B. (2015) · Neuron · doi:10.1016/j.neuron.2015.06.038 · Cited by 178 · see citing works

Tumor Reoxygenation and Blood Perfusion Enhanced Photodynamic Therapy using Ultrathin Graphdiyne Oxide Nanosheets

Jiang, W., Zhang, Z., Wang, Q., Dou, J., Zhao, Y., Ma, Y., Liu, H., Xu, H., & Wang, Y. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b01458 · Cited by 146 · see citing works

The mTOR and PP2A pathways regulate PHD2 phosphorylation to fine-tune HIF1α levels and colorectal cancer cell survival under hypoxia

Di Conza, G., Trusso Cafarello, S., Loroch, S., Mennerich, D., Deschoemaeker, S., Di Matteo, M., Ehling, M., Gevaert, K., Prenen, H., Zahedi, R. P., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.051 · Cited by 119 · see citing works

The tumour hypoxia induced non-coding transcriptome

Choudhry, H., Harris, A. L., & McIntyre, A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.01.003 · Cited by 120 · see citing works

Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis

Lin, C.-W., Wang, L.-K., Wang, S.-P., Chang, Y.-L., Wu, Y.-Y., Chen, H.-Y., Hsiao, T.-H., Lai, W.-Y., Lu, H.-H., Chang, Y.-H., et al. (2016) · Nature Communications · doi:10.1038/ncomms13867 · Cited by 86 · see citing works

The First Tianjin, China Forum on Tumor Microenvironment

Keller, E. T., & Li, L.-Y. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2930 · Cited by 6 · see citing works

PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression

Sui, L., Wang, S., Ganguly, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35649-9 · Cited by 24 · see citing works

Role of the tumor microenvironment in tumor progression and the clinical applications (Review)

YUAN, Y., JIANG, Y.-C., SUN, C.-K., & CHEN, Q.-M. (2016) · Oncology Reports · doi:10.3892/or.2016.4660 · Cited by 320 · see citing works

Tumor microenvironment components: Allies of cancer progression

Franco, P. I. R., Rodrigues, A. P., de Menezes, L. B., & Miguel, M. P. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152729 · Cited by 243 · see citing works

Data from The First Tianjin, China Forum on Tumor Microenvironment

Keller, E. T., & Li, L. (2023) · doi:10.1158/0008-5472.c.6502869.v1